COMP <GO>
GEHC vs NNOX // ENTERPRISE SCALE & MARKET CAP
GE HealthCare Technologies Inc. (NASDAQ) VS. NANO-X IMAGING LTD (NASDAQ) • 15-METRIC TALLY: GEHC 9
— NNOX 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: GEHC
LAST: $76.42 (+0.79%) • MKT CAP: $34.55B
market-cap
$34.55B
LAST: $0.31 (-4.82%) • MKT CAP: $24.0M
market-cap
$24.0M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEHC VS. NNOX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEHC | NNOX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.00% | -30.00% | +70.00 | GEHC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.20% | -35.00% | +49.20 | GEHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.19% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 13.40% | -60.00% | +73.40 | GEHC | /operating-margins <GO> |
| Net Profit Margin | 10.10% | -60.00% | +70.10 | GEHC | /net-margins <GO> |
| Revenue Growth (YoY) | 4.80% | 15.40% | -10.60 | NNOX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 0.00% | +0.19 | GEHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.90 | 0.20 | +1.70 | GEHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 3/9 | +6.00 | GEHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.3 | 21.0 | +52.30 | GEHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $34.55B | $24.0M | $34.53B | GEHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEHC REV | NNOX REV | GEHC GROSS % | NNOX GROSS % | GEHC FCF | NNOX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.63B | $13.0M | 40.0% | -50.0% | — | -$45.0M |
| FY 2024 | $19.67B | $11.3M | 41.7% | -50.0% | — | -$39.4M |
| FY 2023 | $19.55B | $9.9M | — | — | — | -$44.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEHC // BETA 1.15
NNOX // BETA —